The comparison on effectiveness between mopride and acotiamide in the functional dyspepsia patients

The comparison on effectiveness between mopride and acotiamide in the functional dyspepsia patients - Prokinetics for functional dyspepsia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024049

Enrollment

100

Registered

2016-09-15

Start date

2016-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

functional dyspepsia

Interventions

Patients taking mosapride 5mg three times per day for 14 days Patients taking acotiamide 100mg three times per day for 14 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed as functional dyspepsia using ROMA4 criteria

Exclusion criteria

Exclusion criteria: Patients already taking prokinetics patients with changed treatment during the study

Design outcomes

Primary

Measure	Time frame
GSRS score and SF-36 score after taking prokinetics for 14 weeks	—

Secondary

Measure	Time frame
clinical characteristics in the patients with effectiveness	—

Countries

Japan

Contacts

Public ContactShiotani Akiko

Kawasaki Medical School Gastroenterology

shiotani@med.kawasaki-m.ac.jp086-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026